For the Inventor, By the Inventor

Enter assignee name

Shijiazhuang, China

Xuanzhu Biopharmaceutical Co., Ltd.

USPTO Granted Patents = 7

EPO Patents = 4

Forward Citations = 0

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Bo Chen (2 out of 5 patents)

Bin Liu (2 out of 22 patents)

Shouhua Xiao (1 out of 10 patents)

4. Yuntao Song (1 out of 18 patents)

5. Wenkui Ken Fang (1 out of 1 patent)

6. Tingzhong Wang (1 out of 1 patent)

7. Jing Cheng (1 out of 1 patent)

8. Xiaodong Zhu (1 out of 2 patents)

9. Yuzhen Feng (1 out of 3 patents)

10. Lan Fang (1 out of 1 patent)

11. Jianhui Zhou (1 out of 8 patents)

12. Chen Dong (1 out of 2 patents)

13. Ping Hui Szu (1 out of 2 patents)

14. Haibo Wang (1 out of 1 patent)

15. Guohui Han (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12441717 - Crystal form of polycyclic anaplastic lymphoma kinase inhibitor (2025-10-14),

2. 12378299 - CD80 variant proteins and uses thereof (2025-08-05),

3. 12331038 - Hexone glucokinase inhibitor and use thereof (2025-06-17),

4. 12178807 - Macrocyclic tyrosine kinase inhibitor and uses thereof (2024-12-31),

5. 11352358 - FXR agonist (2022-06-07),

6. 11325982 - Biparatopic and multiparatopic antibodies with common light chain and method of use (2022-05-10),

7. 11299474 - Crystal form targeting CDKkinase inhibitor (2022-04-12),

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

7 Patents

#8 in Shijiazhuang

#3,416 in China

Shijiazhuang, China

Xuanzhu Biopharmaceutical Co., Ltd.

Forward Citations = 0

16 inventors:

Bo Chen (2 out of 5 patents)

Bin Liu (2 out of 22 patents)

Shouhua Xiao (1 out of 10 patents)

4. Yuntao Song (1 out of 18 patents)

5. Wenkui Ken Fang (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

Loading…